Advisory Committee on the Medical Uses of Isotopes: Meeting Notice, 57173-57174 [2024-15325]
Download as PDF
Federal Register / Vol. 89, No. 134 / Friday, July 12, 2024 / Notices
lotter on DSK11XQN23PROD with NOTICES1
respondents, or burden-hours per
respondent) and are low-cost for both
the respondents and the Federal
Government;
The collections are non-controversial
and do not raise issues of concern to
other Federal agencies;
Any collection is targeted to the
solicitation of opinions from
respondents who have experience with
the program or may have experience
with the program in the near future;
Information gathered will only be
used internally for general service
improvement and program management
purposes and is not intended for release
outside of the Agency;
Information gathered will not be used
for the purpose of substantially
informing influential policy decisions;
and
Information gathered will yield
qualitative information; the collections
will not be designed or expected to
yield statistically reliable results or used
as though the results are generalizable to
the population of study.
Feedback collected under this generic
clearance provides useful information,
but it does not yield data that can be
generalized to the overall population.
This type of generic clearance for
qualitative information will not be used
for quantitative information collections
that are designed to yield reliably
actionable results, such as monitoring
trends over time or documenting
program performance. Such data uses
require more rigorous designs that
address: The target population to which
generalizations will be made; the
sampling frame; the sample design
(including stratification and clustering);
the precision requirements or power
calculations that justify the proposed
sample size; the expected response rate;
methods for assessing potential nonresponse bias; the protocols for data
collection; and any testing procedures
that were or will be undertaken prior to
fielding the study. Depending on the
degree of influence the results are likely
to have, such collections may still be
eligible for submission for other generic
mechanisms that are designed to yield
quantitative results.
As a general matter, information
collections will not result in any new
system of records containing privacy
information and will not ask questions
of a sensitive nature, such as sexual
behavior and attitudes, religious beliefs,
and other matters that are commonly
considered private.
57173
collection techniques or the use of other
forms of information technology.
Comments submitted in response to
this notice will be summarized and
included in the request for OMB
approval of this information collection.
They will also become a matter of
public record.
Stayce Hoult,
PRA Clearance Officer, National Aeronautics
and Space Administration.
[FR Doc. 2024–15284 Filed 7–11–24; 8:45 am]
BILLING CODE 7510–13–P
III. Data
Title: Generic Clearance for the
Collection of Qualitative Feedback on
Agency Service Delivery.
OMB Number: 2700–0153.
Type of review: Extension of approval
for a collection of information.
Affected Public: Federal Government;
Individuals and Households; Businesses
and Organization; State, Local, or Tribal
Government.
Estimated Annual Number of
Activities: 70.
Estimated Number of Respondents
per Activity: 2,000.
Annual Responses: 140,000.
Estimated Time per Response: 5
minutes.
Estimated Total Annual Burden
Hours: 16,800.
IV. Request for Comments
Comments are invited on: (1) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of NASA, including
whether the information collected has
practical utility; (2) the accuracy of
NASA’s estimate of the burden
(including hours and cost) of the
proposed collection of information; (3)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (4) ways to minimize the
burden of the collection of information
on respondents, including automated
NUCLEAR REGULATORY
COMMISSION
Advisory Committee on the Medical
Uses of Isotopes: Meeting Notice
U.S. Nuclear Regulatory
Commission.
ACTION: Notice of meeting.
AGENCY:
The U.S. Nuclear Regulatory
Commission (NRC) will convene a
meeting of the Advisory Committee on
the Medical Uses of Isotopes (ACMUI)
on August 29, 2024, to discuss the
ACMUI’s draft subcommittee report on
its review and recommendations on
staff’s regulatory basis for the
rulemaking to amend financial
assurance requirements for disposition
of category 1–3 byproduct material
radioactive sealed sources. Meeting
information, including a copy of the
agenda and handouts, will be available
on the ACMUI’s Meetings and Related
Documents web page at https://
www.nrc.gov/reading-rm/doccollections/acmui/meetings/2024.html
or by emailing Ms. L. Armstead at the
contact information below.
Date: August 29, 2024, from 2:00 p.m.
to 4:00 p.m. Eastern Time.
Address for Public Meeting: This is a
virtual meeting.
SUMMARY:
Date
Webinar information (Microsoft Teams)
August 29, 2024 ...................................
Link:
https://teams.microsoft.com/l/meetup-join/19%3ameeting_NmZmMDUwYzgt
NTZlYS00YmI1LWI4OGItMjJjMDYyZGRkNTk2%40thread.v2/0?context=%7b%22Tid%22%3
a%22e8d01475-c3b5-436a-a065-5def4c64f52e%22%2c%22Oid%22%3a%22304f46bf-32c2-4e0f912c-878db895e74a%22%7d.
Meeting ID: 254 136 027 833.
Passcode: nxAuiE.
Call in number (audio only): +301–576–2978, United States, Silver Spring.
Phone Conference ID: 901 692 104#.
Public Participation: The meeting will
be held using Microsoft Teams. Any
member of the public who wishes to
participate in the meeting via Microsoft
Teams or via phone can use the
VerDate Sep<11>2014
16:35 Jul 11, 2024
Jkt 262001
information provided above or should
contact Ms. L. Armstead. Members of
the public should also monitor the
NRC’s Public Meeting Schedule at
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
https://www.nrc.gov/pmns/mtg for any
meeting updates.
Contact Information: Ms. L.
Armstead, email: lxa5@nrc.gov,
telephone: 301–415–1650.
E:\FR\FM\12JYN1.SGM
12JYN1
57174
Federal Register / Vol. 89, No. 134 / Friday, July 12, 2024 / Notices
Conduct of the Meeting
The ACMUI Chair, Dr. Hossein Jadvar
will preside over the meeting. Dr. Jadvar
will conduct the meeting in a manner
that will facilitate the orderly conduct of
business. The following procedures
apply to public participation in the
meeting:
1. Persons who wish to provide a
written statement should submit an
electronic copy to Ms. L. Armstead
using the contact information listed
above. All submittals must be received
by the close of business on August 23,
2024, and must only pertain to the
topics on the agenda.
2. Questions and comments from
members of the public will be permitted
during the meeting, at the discretion of
the ACMUI Chair.
3. The draft transcript and meeting
summary will be available on ACMUI’s
website https://www.nrc.gov/readingrm/doc-collections/acmui/meetings/
2024.html on or about September 23,
2024.
4. Persons who require special
services, such as those for the hearing
impaired, should notify Ms. L.
Armstead of their planned participation.
This meeting will be held in
accordance with the Atomic Energy Act
of 1954, as amended (primarily section
161a); the Federal Advisory Committee
Act (5 U.S.C. app); and the
Commission’s regulations in title 10 of
the Code of Federal Regulations, part 7.
Dated at Rockville, Maryland this 9th day
of July, 2024.
For the U.S. Nuclear Regulatory
Commission.
Russell E. Chazell,
Federal Advisory Committee Management
Officer.
[FR Doc. 2024–15325 Filed 7–11–24; 8:45 am]
BILLING CODE 7590–01–P
POSTAL SERVICE
International Product Change—
Removal of International Money
Transfer Service—Outbound and
International Money Transfer Service—
Inbound
Postal ServiceTM.
ACTION: Notice.
AGENCY:
The Postal Service gives
notice of filing a request with the Postal
Regulatory Commission to remove
International Money Transfer Service—
Outbound, effective October 1, 2024,
and International Money Transfer
Service—Inbound, effective October 1,
2025, from the Competitive Product List
in the Mail Classification Schedule.
lotter on DSK11XQN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
16:35 Jul 11, 2024
Applicable dates: October 1,
2024, and October 1, 2025.
FOR FURTHER INFORMATION CONTACT:
Christopher C. Meyerson, 202–268–
7820.
DATES:
Jkt 262001
The
United States Postal Service® hereby
gives notice that, pursuant to 39 U.S.C.
3642 and 39 CFR 3040.130 et seq., on
July 5, 2024, it filed with the Postal
Regulatory Commission a Request of the
United States Postal Service to Remove
International Money Transfer Service—
Outbound and International Money
Transfer Service—Inbound from the
Competitive Product List in the Mail
Classification Schedule. Documents are
available at www.prc.gov, Docket No.
MC2024–413.
SUPPLEMENTARY INFORMATION:
Christopher Doyle,
Attorney, Ethics and Legal Compliance.
[FR Doc. 2024–15342 Filed 7–11–24; 8:45 am]
BILLING CODE 7710–12–P
SECURITIES AND EXCHANGE
COMMISSION
[SEC File No. 270–522, OMB Control No.
3235–0586]
Submission for OMB Review;
Comment Request; Extension: Rule
38a–1
Upon Written Request, Copies Available
From: Securities and Exchange
Commission, Office of FOIA Services,
100 F Street NE, Washington, DC
20549–2736
Notice is hereby given that, pursuant
to the Paperwork Reduction Act of 1995
(44 U.S.C. 3501 et seq.), the Securities
and Exchange Commission (the
‘‘Commission’’) has submitted to the
Office of Management and Budget a
request for extension of the previously
approved collection of information
discussed below.
Rule 38a–1 (17 CFR 270.38a–1) under
the Investment Company Act of 1940
(15 U.S.C. 80a) (‘‘Investment Company
Act’’) is intended to protect investors by
fostering better fund compliance with
securities laws. The rule requires every
registered investment company and
business development company
(‘‘fund’’) to: (i) adopt and implement
written policies and procedures
reasonably designed to prevent
violations of the federal securities laws
by the fund, including procedures for
oversight of compliance by each
investment adviser, principal
underwriter, administrator, and transfer
agent of the fund; (ii) obtain the fund
board of directors’ approval of those
policies and procedures; (iii) annually
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
review the adequacy of those policies
and procedures and the policies and
procedures of each investment adviser,
principal underwriter, administrator,
and transfer agent of the fund, and the
effectiveness of their implementation;
(iv) designate a chief compliance officer
to administer the fund’s policies and
procedures and prepare an annual
report to the board that addresses
certain specified items relating to the
policies and procedures; and (v)
maintain for five years the compliance
policies and procedures and the chief
compliance officer’s annual report to the
board.
The rule contains certain information
collection requirements that are
designed to ensure that funds establish
and maintain comprehensive, written
internal compliance programs. The
information collections also assist the
Commission’s examination staff in
assessing the adequacy of funds’
compliance programs.
The Commission staff estimates that
13,628 funds are subject to rule 38a–1.
Based on these estimates, the total
annual burden hours associated with
Rule 38a–1 is 476,980 hours. The
estimated total annual burden hours
associated with rule 38a–1 have
increased 25,572 hours, from 451,408
hours to 476,980 hours and external
costs increased from $19,608,000 to
$23,876,256. These changes in burden
hours and external costs reflect changes
in the number of affected entities and in
the external cost associated with the
information collection requirements.
These changes reflect revised estimates.
The estimate of average burden hours
is made solely for the purposes of the
Paperwork Reduction Act. The estimate
is based on communications with
industry representatives and is not
derived from a comprehensive or even
a representative survey or study.
Responses will not be kept confidential.
Other information provided to the
Commission in connection with staff
examinations or investigations is kept
confidential subject to the provisions of
applicable law. If information collected
pursuant to rule 38a–1 is reviewed by
the Commission’s examination staff, it is
accorded the same level of
confidentiality accorded to other
responses provided to the Commission
in the context of its examination and
oversight program. An agency may not
conduct or sponsor, and a person is not
required to respond to, a collection of
information unless it displays a
currently valid OMB control number.
The public may view background
documentation for this information
collection at the following website:
www.reginfo.gov. Find this particular
E:\FR\FM\12JYN1.SGM
12JYN1
Agencies
[Federal Register Volume 89, Number 134 (Friday, July 12, 2024)]
[Notices]
[Pages 57173-57174]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-15325]
=======================================================================
-----------------------------------------------------------------------
NUCLEAR REGULATORY COMMISSION
Advisory Committee on the Medical Uses of Isotopes: Meeting
Notice
AGENCY: U.S. Nuclear Regulatory Commission.
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) will convene a
meeting of the Advisory Committee on the Medical Uses of Isotopes
(ACMUI) on August 29, 2024, to discuss the ACMUI's draft subcommittee
report on its review and recommendations on staff's regulatory basis
for the rulemaking to amend financial assurance requirements for
disposition of category 1-3 byproduct material radioactive sealed
sources. Meeting information, including a copy of the agenda and
handouts, will be available on the ACMUI's Meetings and Related
Documents web page at https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2024.html or by emailing Ms. L. Armstead at the contact
information below.
Date: August 29, 2024, from 2:00 p.m. to 4:00 p.m. Eastern Time.
Address for Public Meeting: This is a virtual meeting.
------------------------------------------------------------------------
Date Webinar information (Microsoft Teams)
------------------------------------------------------------------------
August 29, 2024.............. Link: https://teams.microsoft.com/l/meetup-join/19%3ameeting_NmZmMDUwYzgtNTZlYS00YmI1LWI4OGItMjJjMDYyZGRkNTk2%40thread.v2/0?context=%7b%22Tid%22%3a%22e8d01475-c3b5-436a-a065-5def4c64f52e%22%2c%22Oid%22%3a%22304f46bf-32c2-4e0f-912c-878db895e74a%22%7d.
Meeting ID: 254 136 027 833.
Passcode: nxAuiE.
Call in number (audio only): +301-576-
2978, United States, Silver Spring.
Phone Conference ID: 901 692 104#.
------------------------------------------------------------------------
Public Participation: The meeting will be held using Microsoft
Teams. Any member of the public who wishes to participate in the
meeting via Microsoft Teams or via phone can use the information
provided above or should contact Ms. L. Armstead. Members of the public
should also monitor the NRC's Public Meeting Schedule at https://www.nrc.gov/pmns/mtg for any meeting updates.
Contact Information: Ms. L. Armstead, email: [email protected],
telephone: 301-415-1650.
[[Page 57174]]
Conduct of the Meeting
The ACMUI Chair, Dr. Hossein Jadvar will preside over the meeting.
Dr. Jadvar will conduct the meeting in a manner that will facilitate
the orderly conduct of business. The following procedures apply to
public participation in the meeting:
1. Persons who wish to provide a written statement should submit an
electronic copy to Ms. L. Armstead using the contact information listed
above. All submittals must be received by the close of business on
August 23, 2024, and must only pertain to the topics on the agenda.
2. Questions and comments from members of the public will be
permitted during the meeting, at the discretion of the ACMUI Chair.
3. The draft transcript and meeting summary will be available on
ACMUI's website https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2024.html on or about September 23, 2024.
4. Persons who require special services, such as those for the
hearing impaired, should notify Ms. L. Armstead of their planned
participation.
This meeting will be held in accordance with the Atomic Energy Act
of 1954, as amended (primarily section 161a); the Federal Advisory
Committee Act (5 U.S.C. app); and the Commission's regulations in title
10 of the Code of Federal Regulations, part 7.
Dated at Rockville, Maryland this 9th day of July, 2024.
For the U.S. Nuclear Regulatory Commission.
Russell E. Chazell,
Federal Advisory Committee Management Officer.
[FR Doc. 2024-15325 Filed 7-11-24; 8:45 am]
BILLING CODE 7590-01-P